Life sciences companies including pharmaceuticals, medical device manufacturers and biotechnology organizations hold some of the most sensitive data of any industry, including patient information, patented drugs, clinical trials, research projects and manufacturing processes.This, combined with the direct impact to human health and safety of their products, makes life sciences companies particularly consequential targets for cyberattacks. This whitepaper draws upon the insights from Honeywell’s control system cybersecurity specialists, working in 130+ countries on 7,000+ cybersecurity projects over 25 years. In addition, it taps into Honeywell’s extensive experience providing quality management, manufacturing execution systems, distributed control systems and batch historians to life sciences for more than 40 years. By combining these typically distinct views, an operations leader can gain broader context within which to make informed decisions on actions and next steps to improve cybersecurity in operational technology (OT) settings without impacting business operations and production.

Join for free to read